Important News | Yinguan Bio's Participation in Drafting the Group Standard "Guidelines for Clinical Application of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Stroke" Officially Releasedby wingorSeptember 9, 2026October 23, 2026
Continued Breakthroughs | Yinguan Biotechnology's Stem Cell Drug Pipeline: A Detailed Reportby wingorSeptember 8, 2026October 23, 2026
Technological Innovation | Inglos Biotech's "Pretreated Mesenchymal Stem Cell Therapy for Stroke" Technology Submits PCT International Patent Applicationby wingorSeptember 7, 2026October 23, 2026
Good News | The "Research on Minimally Invasive Delivery Technology and Devices for Stroke Stem Cells," in which Yinguan Bio participated, is proposed to receive funding from the 2026 Shenzhen Medical Special Fund.by wingorSeptember 2, 2026October 23, 2026
News | Ingenic Biotech's latest stem cell drug IND application accepted!by wingorJune 18, 2026June 25, 2026
Event Announcement | ATMP 2026 is about to begin; Ingloun Biotech invites you to explore the forefront of cell therapy.by wingorJune 2, 2026June 3, 2026
Inglos Biotech was invited to attend the Sanya Food and Drug Summit to share its clinical progress in stem cell therapy for end-stage liver disease.by alexMay 11, 2026June 2, 2026
Inglos Biotech was awarded "CGT Leading Enterprise" and participated deeply in the 2026 Greater Bay Area Seminar on the Development of the Biopharmaceutical Industry and the 4th Seeking Truth in Cell and Gene Industry Development Forum | Seeking Truth and Moving Forward with Honorsby alexApril 20, 2026May 24, 2026
Breaking News | Inglos Biotech, in collaboration with the School of Pharmacy of Sun Yat-sen University, publishes an SCI paper: Bioactive Panax notoginseng-derived nanovesicles rich in EGF accelerate skin wound healing.by alexMarch 18, 2026May 25, 2026
From Clinical Breakthroughs to Global Technology Expansion | Inglourio Biotech Invited to Attend BIOCHINA 2026, Participating in Keynote Speeches and Roundtable Discussionsby alexMarch 16, 2026May 24, 2026
